Drug intelligence / Profile preview

Ruyong formula (Shanghai Fourth People's Hospital)

Development stage: Unknown
Lead developer: Shanghai Fourth People's Hospital
Administration: Oral

Overview

Ruyong formula is a Traditional Chinese Medicine (TCM) herbal preparation developed for the treatment of infectious lactational mastitis. In TCM, "Ruyong" refers specifically to mastitis, characterized by breast swelling, pain, and heat. The formula typically consists of a combination of herbs known for their heat-clearing, detoxifying, and swelling-reducing properties. It is being evaluated by the Shanghai Fourth People's Hospital Affiliated to Tongji University as an adjunctive therapy to standard antibiotics to improve clinical outcomes and reduce the progression of early-stage mastitis to abscess formation.

Other names: Ruqi PrescriptionRuyong decoctionRuyong prescription

Beyond the preview

Go deeper on Ruyong formula (Shanghai Fourth People's Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruyong formula (Shanghai Fourth People's Hospital).

Explore the full profile